Canlyniadau Chwilio - Sohn, Joohyuk

Increased resting-state cerebellar-cortical connectivity in breast cancer survivors with cognitive complaints after chemotherapy gan Park, Hye Yoon, Lee, Hyeongrae, Sohn, Joohyuk, An, Suk Kyoon, Namkoong, Kee, Lee, Eun

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Talazoparib versus Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of... gan Lee, Kyung-Hun, Sohn, Joohyuk, Goodwin, Annabel, Usari, Tiziana, Lanzalone, Silvana, Im, Seock-Ah, Kim, Sung-Bae

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer gan Lee, Jeong Dong, Ryu, Won-Ji, Han, Hyun Ju, Kim, Tae Yeong, Kim, Min Hwan, Sohn, Joohyuk

Cael y testun llawn Cael y testun llawn Cael y testun llawn

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer gan Sohn, Joohyuk, Liu, Shuying, Parinyanitikul, Napa, Lee, Jangsoon, Hortobagyi, Gabriel N., Mills, Gordon B., Ueno, Naoto T., Gonzalez-Angulo, Ana M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer gan Hyun, Kyung-A, Koo, Gi-Bang, Han, Hyunju, Sohn, Joohyuk, Choi, Wonshik, Kim, Seung-Il, Jung, Hyo-Il, Kim, You-Sun

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis gan Cha, Chihwan, Ahn, Sung Gwe, Yoo, Tae-Kyung, Kim, Kun Min, Bae, Soong June, Yoon, Changik, Park, Soeun, Sohn, Joohyuk, Jeong, Joon

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs gan Hata, Tomomi, Nakamura, Kenichi, Yonemori, Kan, Noguchi, Emi, Watanabe, Makiko, Sohn, Joohyuk, Lu, Yen‐Shen, Yap, Yoon‐Sim, Tamura, Kenji, Fujiwara, Yasuhiro

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review gan Pandey, Kamal, An, Hee‐Jung, Kim, Seung Ki, Lee, Seung Ah, Kim, Sewha, Lim, Sun Min, Kim, Gun Min, Sohn, Joohyuk, Moon, Yong Wha

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide gan Kim, Gun Min, Kim, Joo Hoon, Kim, Ji Heung, Cho, Young Up, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Ji Ye, Sohn, Joohyuk

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups gan Johnston, Stephen, O’Shaughnessy, Joyce, Martin, Miguel, Huober, Jens, Toi, Masakazu, Sohn, Joohyuk, André, Valérie A. M., Martin, Holly R., Hardebeck, Molly C., Goetz, Matthew P.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR gan Park, Hyung Seok, Han, Hyun Ju, Lee, Soohyeon, Kim, Gun Min, Park, Seho, Choi, Yeon A, Lee, Jeong Dong, Kim, Gi Moon, Sohn, Joohyuk, Kim, Seung Il

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy gan Kaufman, Peter A., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Grischke, Eva‐Maria, Andre, Valerie, Stoffregen, Clemens, Shekarriz, Sarah, Price, Gregory L., Carter, Gebra Cuyun, Sledge, George W.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy gan Kim, Chang Gon, Sohn, Joohyuk, Chon, Hongjae, Kim, Joo Hoon, Heo, Su Jin, Cho, Hyunsoo, Kim, In Jung, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Gun Min

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results gan Park, Hyung Seok, Park, Seo-Jin, Kim, Jee Ye, Kim, Sanghwa, Ryu, Jaegyu, Sohn, Joohyuk, Park, Seho, Kim, Gun Min, Hwang, In Sik, Choi, Jong-Rak, Kim, Seung Il

Cael y testun llawn Cael y testun llawn Cael y testun llawn

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial gan Moon, Yong Wha, Lee, Soohyeon, Park, Byeong-Woo, Kim, Eun-Kyung, Kim, Seung Il, Koo, Ja Seung, Park, Seho, Kim, Min Jung, Chung, Hyun Cheol, Kim, Joo-Hang, Sohn, Joohyuk

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer gan Ahn, Sung Gwe, Lee, Jae-Hoon, Lee, Hak Woo, Jeon, Tae Joo, Ryu, Young Hoon, Kim, Kun Min, Sohn, Joohyuk, Yun, Mijin, Lee, Seung Ah, Jeong, Joon, Kim, Seung Il

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer (IBC): Prevalence, Clinicopathologic Features and Prognostic Implication gan Kim, Min Hwan, Lee, Soohyeon, Koo, Ja Seung, Jung, Kyung Hae, Park, In Hae, Jeong, Joon, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Park, Byeong-Woo, Kim, Joo-Hang, Sohn, Joohyuk

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy gan Jung, Minkyu, Koo, Ja Seung, Moon, Young Wha, Park, Byeong-Woo, Kim, Seung Il, Park, Seho, Lee, Soo Hyun, Hong, Soojung, Rha, Sun Young, Chung, Hyun Cheol, Kim, Joo Hang, Sohn, Joohyuk

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer gan Bae, Soong June, Kim, Jee Hung, Ahn, Sung Gwe, Jeung, Hei-Cheul, Sohn, Joohyuk, Kim, Gun Min, Kim, Min Hwan, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Ji Ye, Jeong, Joon

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer gan Chae, Young Kwang, Gagliato, Debora de Melo, Pai, Sachin Gopalkrishna, Carneiro, Benedito, Mohindra, Nisha, Giles, Francis Joseph, Ramakrishnan-Geethakumari, Praveen, Sohn, Joohyuk, Liu, Shuying, Chen, Huiqin, Ueno, Naoto, Hortobagyi, Gabriel, Gonzalez-Angulo, Ana Maria

Cael y testun llawn Cael y testun llawn Cael y testun llawn